SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm January 12, 2021 06:00 ET | Source: Barr Law Group Barr Law Group San Diego, California, UNITED STATES SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating the actions of the officers and board of directors of Sarepta Therapeutics, Inc., Pluralsight, Inc., RealPage, Inc., and Principal Real Estate Income Fund. If you are a current owner of shares of any of these stocks, contact leo@barrlaw.com or call (619) 400-4966. Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Barr Law Group is investigating Sarepta Therapeutics, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders. On January 7, 2021, Sarepta revealed that its one-time gene therapy for Duchenne muscular dystrophy did not show benefits compared to a placebo. Following this news, Sarepta stock dropped roughly 49.7%, during after-market trading, and opened at $85.00 on January 8, 2021. To learn more about this investigation and your rights, visit: http://barrlaw.com/investor-contact. Representation is contingency based, no out of pocket costs.